OR WAIT null SECS
February 02, 2014
High technology assessments are having an impact on biosimilars development in Europe.
January 30, 2014
EMA's guidance focuses on the use of pharmacogenomics to improve drug safety monitoring.
January 24, 2014
FDA adds Ranbaxy's Toansa, India facility to existing consent decree, prohibiting distribution of APIs from that location
January 09, 2014
FDA releases guidance on developing drugs for the treatment of community-acquired bacterial pneumonia.
December 16, 2013
Agency issues precautionary recall due to manufacturing fault.
December 12, 2013
Teva Pharmaceutical Industries releases a financial outlook for 2014 based on two possible scenarios concerning its multiple-sclerosis drug Copaxone (glatiramer acetate).
November 28, 2013
Baxter has issued a voluntary recall of one lot of nitroglycerin in 5% dextrose injection after particulate matter was found in one vial.
November 26, 2013
European Medicines Agency announces the launch of the Accelerated development of vaccine benefit-risk collaboration in Europe (ADVANCE) project.
November 07, 2013
Includes a new approach on developing antibacterial agents targeted against multidrug-resistant (MDR) pathogens where patients have very limited or no remaining treatment options.